| 今开：1.45 | 昨收：1.435 |
| 最高：1.45 | 最低：1.41 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.774076E7 |
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066659 Size: 4 KB 网页链接查看全文
Spero Therapeutics(SPRO)06-04 04:25
$Spero Therapeutics(SPRO)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001193125-24-153034 Act: 34 Size: 299 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-16 04:05
$Spero Therapeutics(SPRO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060400 Act: 34 Size: 7 MB 网页链接查看全文
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066625 Size: 5 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066624 Size: 4 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066652 Size: 4 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-16 04:25
$Spero Therapeutics(SPRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-139364 Act: 34 Size: 203 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066616 Size: 4 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066619 Size: 4 KB 网页链接查看全文
Spero Therapeutics(SPRO)05-31 04:35
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066622 Size: 4 KB 网页链接查看全文
chuminhua2019-01-08 00:26
$Spero治疗(SPRO)$
1/7，Spero Therapeutics称，根据与FDA的讨论，其SPR994口服治疗复杂性尿路感染（cUTI）在关键性III期临床试验的结果足以支持批准，为此提交了该药的申请，并计划在Q1开始ADAPT-PO III期研究作为批准所需的辅助性研究。网页链接查看全文
淘沙见金2017-11-02 11:49
$Spero Therapeutics, Inc.(SPRO)$ 明天IPO，做抗生素的，还在做临床一期。现在做抗生素的临床晚期AKAO/PRTK日子都不好过，实在搞不懂哪里来的勇气IPO，更搞不懂背后居然还有RA Capital的支持。另外一个$Allena Pharmaceuticals, Inc.(ALNA)$ 也是两个二期失败，执意继续三期，不过背后有Third Roc...查看全文
智通财经APP获悉，7月1日（周四）美股盘前，Spero Therapeutics(SPRO.US)股价上涨，截止至19:12，涨28.51%，报17.94美元。据报道，公司获得了来自辉瑞(PFE.US)的4000万美元股权投资。根据协议，该公司已授予辉瑞公司在前美国和前亚洲地... 网页链接
$Spero Therapeutics(SPRO)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001193125-24-153034 Act: 34 Size: 299 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066616 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066617 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066619 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066625 Size: 5 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066624 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066622 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066652 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-066659 Size: 4 KB 网页链接
$Spero Therapeutics(SPRO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-139364 Act: 34 Size: 203 KB 网页链接